Profiling of human myotubes reveals an intrinsic proteomic signature associated with type 2 diabetes

Translational Proteomics

Volumn 2, Issue 1, 2014, Pages 25-38

  Al Khalili, Lubna ^a,c   de Castro Barbosa, Thais ^a   Östling, Jörgen ^b   Massart, Julie ^a   Katayama, Mutsumi ^a   Nyström, Ann Christin ^b   Oscarsson, Jan ^b   Zierath, Juleen R ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Cytoskeleton; Gene regulation; In vitro; Metabolism; Oxidative stress defense; Protein folding and degradation; Protein homeostasis maintenance; Proteome; Satellite cells; Skeletal muscle

Indexed keywords

CHOLESTEROL; DJ 1 PROTEIN; GLUCOSE TRANSPORTER 4; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M2; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 90; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN; METFORMIN; PHENYLALANINE; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; SULFONYLUREA;

ADULT; AMINO ACID METABOLISM; AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CELL SURVIVAL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; DIABETIC DIET; DISEASE ASSOCIATION; DISEASE COURSE; DNA REPAIR; ENERGY METABOLISM; EPIGENETICS; FATTY ACID METABOLISM; GENE CONTROL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUTATHIONE METABOLISM; GLYCOGEN SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MITOCHONDRIAL DYNAMICS; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEOMICS; RNA PROCESSING; SKELETAL MUSCLE; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84994460719     PISSN: 22129626     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trprot.2013.12.002     Document Type: Article

References (81)

1. Capeau J. Insulin resistance and steatosis in humans. Diabetes Metab 2008, 34:649-657.
2. Kahn B.B., Flier J.S. Obesity and insulin resistance. J Clin Invest 2000, 106:473-481.
3. DeFronzo R.A., Bonadonna R.C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992, 15:318-368.
4. DeFronzo R.A., Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 2009, 32(Suppl. 2):S157-S163.
5. Scott L.J., Mohlke K.L., Bonnycastle L.L., Willer C.J., Li Yun, Duren W.L., et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
6. Leahy J.L., Boyd A.E. Diabetes genes in non-insulin-dependent diabetes mellitus. N Engl J Med 1993, 328:56-57.
7. McIntyre E.A., Halse R., Yeaman S.J., Walker M. Cultured muscle cells from insulin-resistant type 2 diabetes patients have impaired insulin, but normal 5-amino-4-imidazolecarboxamide riboside-stimulated, glucose uptake. J Clin Endocrinol Metab 2004, 89:3440-3448.
8. Sreekumar R., Halvatsiotis P., Schimke J.C., Nair K.S. Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 2002, 51:1913-1920.
9. Mootha V.K., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003, 34:267-273.
10. Patti M.E., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 2003, 100:8466-8471.
11. Pagel-Langenickel I., Bao J., Pang L., Sack M.N. The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endocr Rev 2009, 31:25-51.
12. Gonzalez-Sanchez J.L., Serrano-Rios M. Molecular basis of insulin action. Drug News Perspect 2007, 20:527-531.
13. Olefsky J.M. The insulin receptor: its role in insulin resistance of obesity and diabetes. Diabetes 1976, 25:1154-1162.
14. Cusi K., et al. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000, 105:311-320.
15. Le Roith D., Zick Y. Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 2001, 24:588-597.
16. Ptitsyn A., Hulver M., Cefalu W., York D., Smith S.R. Unsupervised clustering of gene expression data points at hypoxia as possible trigger for metabolic syndrome. BMC Genomics 2006, 7:318.
17. Bullo M., Garcia-Lorda P., Megias I., Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003, 11:525-531.
18. Jones T.H. Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome. J Diabetes 2010, 2:146-156.
19. Gearhart J.D., Mintz B. Creatine kinase, myokinase, and acetylcholinesterase activities in muscle-forming primary cultures of mouse teratocarcinoma cells. Cell 1975, 6:61-66.
20. Thompson D.B., Pratley R., Ossowski V. Human primary myoblast cell cultures from non-diabetic insulin resistant subjects retain defects in insulin action. J Clin Invest 1996, 98:2346-2350.
21. Henry R.R., Ciaraldi T.P., Mudaliar S., Abrams L., Nikoulina S.E. Acquired defects of glycogen synthase activity in cultured human skeletal muscle cells: influence of high glucose and insulin levels. Diabetes 1996, 45:400-407.
22. Unlu M., Morgan M.E., Minden J.S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18:2071-2077.
23. Lilley K.S., Friedman D.B. All about DIGE: quantification technology for differential-display 2D-gel proteomics. Expert Rev Proteomics 2004, 1:401-409.
24. Yan J.X., et al. Separation and identification of rat skeletal muscle proteins using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2001, 1:424-434.
25. Gomez-Lechon M.J., Donato T., Ponsoda X., Castell J.V. Human hepatic cell cultures: in vitro and in vivo drug metabolism. Altern Lab Anim 2003, 31:257-265.
26. Takahashi J.S., Hong H.K., Ko C.H., McDearmon E.L. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 2008, 9:764-775.
27. Thingholm T.E., Bak S., Beck-Nielsen H., Jensen O.N., Gaster M. Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods. Mol Cell Proteomics 2011, 10. M110.006650.
28. Colzani M., Schutz F., Potts A., Waridel P., Quadroni M. Relative protein quantification by isobaric SILAC with immonium ion splitting (ISIS). Mol Cell Proteomics 2008, 7:927-937.
29. Al-Khalili L., et al. Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content. Cell Mol Life Sci 2003, 60:991-998.
30. Rune A., et al. Evidence against a sexual dimorphism in glucose and fatty acid metabolism in skeletal muscle cultures from age-matched men and post-menopausal women. Acta Physiol (Oxf) 2009, 197:207-215.
31. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969, 27:502-522.
32. Palsgaard J., et al. Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways. PLoS ONE 2009, 4:e6575.
33. Hojlund K., et al. Characterization of the human skeletal muscle proteome by one-dimensional gel electrophoresis and HPLC-ESI-MS/MS. Mol Cell Proteomics 2008, 7:257-267.
34. Hwang H., et al. Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes. Diabetes 2010, 59:33-42.
35. Stentz F.B., Kitabchi A.E. Transcriptome and proteome expressions involved in insulin resistance in muscle and activated T-lymphocytes of patients with type 2 diabetes. Genomics Proteomics Bioinformatics 2007, 5:216-235.
36. DeFronzo R.A., Gunnarsson R., Björkman O., Olsson M., Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (Type II) diabetes mellitus. J Clin Invest 1985, 76:149-155.
37. Himsworth H.P. Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types. Diabet Med 2011, 28:1440-1444.
38. Kelley D.E., Mandarino L.J. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 2000, 49:677-683.
39. Kelley D.E., Simoneau J.A. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 1994, 94:2349-2356.
40. Schrauwen-Hinderling V.B., et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia 2007, 50:113-120.
41. Ritov V.B., et al. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am J Physiol Endocrinol Metab 2010, 298:E49-E58.
42. Belfiore F., Romeo F., Napoli E. Enzymes of citrate-cleavage pathway in liver of subjects with adult-onset diabetes. Enzyme 1977, 22:70-72.
43. Deng W.J., Nie S., Dai J., Wu J.R., Zeng R. Proteome, phosphoproteome, and hydroxyproteome of liver mitochondria in diabetic rats at early pathogenic stages. Mol Cell Proteomics 2010, 9:100-116.
44. Qiu J., et al. Gene expression profiles of adipose tissue of high-fat diet-induced obese rats by cDNA microarrays. Mol Biol Rep 2011.
45. Yechoor V.K., Patti M.E., Saccone R., Kahn C.R. Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice. Proc Natl Acad Sci U S A 2002, 99:10587-10592.
46. Sundaram R.K., et al. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 1996, 90:255-260.
47. Hayes J.D., et al. The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochem Soc Trans 2000, 28:33-41.
48. Ballatori N., et al. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 2009, 390:191-214.
49. Whiting P.H., Kalansooriya A., Holbrook I., Haddad F., Jennings P.E. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. Br J Biomed Sci 2008, 65:71-74.
50. Sekhar R.V., et al. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care 2011, 34:162-167.
51. Casas S., et al. Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis. Diabetes 2007, 56:2284-2294.
52. Liu L., et al. Heat shock protein 27 regulates oxidative stress-induced apoptosis in cardiomyocytes: mechanisms via reactive oxygen species generation and Akt activation. Chin Med J (Engl) 2007, 120:2271-2277.
53. McCarty M.F. Induction of heat shock proteins may combat insulin resistance. Med Hypotheses 2006, 66:527-534.
54. Hooper P.L. Inflammation, heat shock proteins, and type 2 diabetes. Cell Stress Chaperones 2009, 14:113-115.
55. Luce K., Weil A.C., Osiewacz H.D. Mitochondrial protein quality control systems in aging and disease. Adv Exp Med Biol 2010, 694:108-125.
56. Altieri D.C., Stein G.S., Lian J.B., Languino L.R. TRAP-1, the mitochondrial Hsp90. Biochim Biophys Acta 2012, 1823:767-773.
57. Takemoto K., Miyata S., Takamura H., Katayama T., Tohyama M. Mitochondrial TRAP1 regulates the unfolded protein response in the endoplasmic reticulum. Neurochem Int 2011, 58:880-887.
58. Raman A.V., et al. Evidence of oxidative stress in young and aged DJ-1-deficient mice. FEBS Lett 2013, 587:1562-1570.
59. Allard L., et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem 2005, 51:2043-2051.
60. Fulda S., Gorman A.M., Hori O., Samali A. Cellular stress responses: cell survival and cell death. Int J Cell Biol 2010, 2010:214074.
61. Andres-Mateos E., et al. DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc Natl Acad Sci U S A 2007, 104:14807-14812.
62. Minet A.D., Gaster M. Hydrogen peroxide production is not primarily increased in human myotubes established from type 2 diabetic subjects. J Clin Endocrinol Metab 2011, 96:E1486-E1490.
63. Trabucchi M., et al. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 2009, 459:1010-1014.
64. Gherzi R., et al. The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol 2006, 5:e5.
65. Briata P., et al. p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Mol Cell 2005, 20:891-903.
66. Onay-Besikci A., et al. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts. Can J Physiol Pharmacol 2007, 85:527-535.
67. Consortium W.T.C.C. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 2007, 447:661-678.
68. Boquist L., Ericsson I., Lorentzon R., Nelson L. Alterations in mitochondrial aconitase activity and respiration, and in concentration of citrate in some organs of mice with experimental or genetic diabetes. FEBS Lett 1985, 183:173-176.
69. Oppermann U. Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology. Annu Rev Pharmacol Toxicol 2007, 47:293-322.
70. Rufer A.C., et al. The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatment. Structure 2006, 14:713-723.
71. Mullen E., Ohlendieck K. Proteomic profiling of non-obese type 2 diabetic skeletal muscle. Int J Mol Med 2010, 25:445-458.
72. Lu H., Yang Y., Allister E.M., Wijesekara N., Wheeler M.B. The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach. Mol Cell Proteomics 2008, 7:1434-1451.
73. Hossaini A.M., Zamrroni I.M., Kashem R.A., Khan Z.F. Polymorphism of glutathione S-transferases as genetic risk factors for the development of complications in type 2 diabetes mellitus. J Crit Care 2008, 23:444-448.
74. Manfredi S., et al. Glutathione S-transferase T1- and M1-null genotypes and coronary artery disease risk in patients with Type 2 diabetes mellitus. Pharmacogenomics 2009, 10:29-34.
75. Lo J.C., Zhao X., Scuteri A., Brockwell S., Sowers M.R. The association of genetic polymorphisms in sex hormone biosynthesis and action with insulin sensitivity and diabetes mellitus in women at midlife. Am J Med 2006, 119:S69-S78.
76. Nair K.S., et al. Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 2008, 57:1166-1175.
77. Chu C.H., Cheng D. Expression, purification, characterization of human 3-methylcrotonyl-CoA carboxylase (MCCC). Protein Expr Purif 2007, 53:421-427.
78. Sanchez J.C., et al. Effect of rosiglitazone on the differential expression of diabetes-associated proteins in pancreatic islets of C57Bl/6 lep/lep mice. Mol Cell Proteomics 2002, 1:509-516.
79. Khalifa A., Cohen M.P. Glomerular protocollagen lysyl-hydroxylase activity in streptozotocin diabetes. Biochim Biophys Acta 1975, 386:332-339.
80. Elbein S.C., Das S.K., Hallman D.M., Hanis C.L., Hasstedt S.J. Genome-wide linkage and admixture mapping of type 2 diabetes in African American families from the American Diabetes Association GENNID (Genetics of NIDDM) Study Cohort. Diabetes 2009, 58:268-274.
81. Reynet C., Kahn C.R. Unbalanced expression of the different subunits of elongation factor 1 in diabetic skeletal muscle. Proc Natl Acad Sci U S A 2001, 98:3422-3427.